Style | Citing Format |
---|---|
MLA | Yazdani R, Aghamohammadi A, Rezaei N. "Application of Flow Cytometry in Predominantly Antibody Deficiencies." Endocrine# Metabolic and Immune Disorders - Drug Targets, vol. 21, no. 4, 2021, pp. 647-663. |
APA | Yazdani R, Aghamohammadi A, Rezaei N (2021). Application of Flow Cytometry in Predominantly Antibody Deficiencies. Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(4), 647-663. |
Chicago | Yazdani R, Aghamohammadi A, Rezaei N. "Application of Flow Cytometry in Predominantly Antibody Deficiencies." Endocrine# Metabolic and Immune Disorders - Drug Targets 21, no. 4 (2021): 647-663. |
Harvard | Yazdani R, Aghamohammadi A, Rezaei N (2021) 'Application of Flow Cytometry in Predominantly Antibody Deficiencies', Endocrine# Metabolic and Immune Disorders - Drug Targets, 21(4), pp. 647-663. |
Vancouver | Yazdani R, Aghamohammadi A, Rezaei N. Application of Flow Cytometry in Predominantly Antibody Deficiencies. Endocrine# Metabolic and Immune Disorders - Drug Targets. 2021;21(4):647-663. |
BibTex | @article{ author = {Yazdani R and Aghamohammadi A and Rezaei N}, title = {Application of Flow Cytometry in Predominantly Antibody Deficiencies}, journal = {Endocrine# Metabolic and Immune Disorders - Drug Targets}, volume = {21}, number = {4}, pages = {647-663}, year = {2021} } |
RIS | TY - JOUR AU - Yazdani R AU - Aghamohammadi A AU - Rezaei N TI - Application of Flow Cytometry in Predominantly Antibody Deficiencies JO - Endocrine# Metabolic and Immune Disorders - Drug Targets VL - 21 IS - 4 SP - 647 EP - 663 PY - 2021 ER - |